Literature DB >> 3021509

Developmental genetics.

C J Epstein.   

Abstract

Of particular concern to the human geneticist are the effects of genetic abnormalities on development. To gain an understanding of these effects it is necessary to engage in a reciprocal process of using knowledge of normal developmental events to elucidate the mechanisms operative in abnormal situations and then of using what is learned about these abnormal situations to expand our understanding of the normal. True developmental genes have not been described in man, although it is likely that they exist, but many developmental abnormalities are ascribable to mutations in genes coding for enzymes and structural proteins. Some of these even produce multiple malformation syndromes with dysmorphic features. These situations provide a precedent for asserting that not only monogenic developmental abnormalities, but also abnormalities resulting from chromosome imbalance must ultimately be explicable in molecular terms. However, the major problem confronted by the investigator interested in the pathogenesis of any of the chromosome anomaly syndromes is to understand how the presence of an extra set of normal genes or the loss of one of two sets of genes has an adverse effect on development. Several molecular mechanisms for which limited precedents exist may be considered on theoretical grounds. Because of the difficulties in studying developmental disorders in man, a variety of experimental systems have been employed. Particularly useful has been the mouse, which provides models for both monogenic and aneuploidy produced abnormalities of development. An example of the former is the mutation oligosyndactylism which in the heterozygous state causes oligosyndactyly and in the homozygous state causes early embryonic mitotic arrest. All whole arm trisomies and monosomies of the mouse can be produced experimentally, and of special interest is mouse trisomy 16 which has been developed as an animal model of human trisomy 21 (Down syndrome). In the long run, the most direct approach to elucidating the genetic problems of human development will involve not only the study of man himself but also of the appropriate experimental models in other species.

Entities:  

Mesh:

Year:  1986        PMID: 3021509     DOI: 10.1007/bf01941286

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  75 in total

1.  In vivo and in vitro studies on the early embryonic lethal oligosyndactylism (Os) in the mouse.

Authors:  H F Paterson
Journal:  J Embryol Exp Morphol       Date:  1979-08

2.  Comparative gene mapping of human chromosome 21 and mouse chromosome 16.

Authors:  D R Cox; C J Epstein
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

3.  Studies on syndrome of diabetes insipidus associated with oligosyndactyly in mice.

Authors:  A D Stewart; J Stewart
Journal:  Am J Physiol       Date:  1969-10

Review 4.  Value of an animal model for trisomy.

Authors:  A Gropp
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

Review 5.  Down syndrome--a disruption of homeostasis.

Authors:  B L Shapiro
Journal:  Am J Med Genet       Date:  1983-02

Review 6.  Genetic disorders of collagen metabolism.

Authors:  D W Hollister; P H Byers; K A Holbrook
Journal:  Adv Hum Genet       Date:  1982

7.  The development of monosomy 19 mouse embryos.

Authors:  T Magnuson; S Smith; C J Epstein
Journal:  J Embryol Exp Morphol       Date:  1982-06

8.  A cytogenetic study of spontaneous abortions in Hawaii.

Authors:  T J Hassold; A Matsuyama; I M Newlands; J S Matsuura; P A Jacobs; B Manuel; J Tsuei
Journal:  Ann Hum Genet       Date:  1978-05       Impact factor: 1.670

9.  Analysis of two-dimensional protein patterns from mouse embryos with different trisomies.

Authors:  J Klose; B Putz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Trisomy 16 in the mouse fetus associated with generalized edema and cardiovascular and urinary tract anomalies.

Authors:  S Miyabara; A Gropp; H Winking
Journal:  Teratology       Date:  1982-06
View more
  8 in total

1.  An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach.

Authors:  Giovanna Cenini; Ada Fiorini; Rukhsana Sultana; Marzia Perluigi; Jian Cai; Jon B Klein; Elizabeth Head; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-08-20       Impact factor: 7.376

2.  Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome.

Authors:  Lina Chakrabarti; Tyler K Best; Nathan P Cramer; Rosalind S E Carney; John T R Isaac; Zygmunt Galdzicki; Tarik F Haydar
Journal:  Nat Neurosci       Date:  2010-07-18       Impact factor: 24.884

3.  Contribution of the two genes encoding histone variant h3.3 to viability and fertility in mice.

Authors:  Michelle C W Tang; Shelley A Jacobs; Deidre M Mattiske; Yu May Soh; Alison N Graham; An Tran; Shu Ly Lim; Damien F Hudson; Paul Kalitsis; Moira K O'Bryan; Lee H Wong; Jeffrey R Mann
Journal:  PLoS Genet       Date:  2015-02-12       Impact factor: 5.917

4.  A random effects model for the identification of differential splicing (REIDS) using exon and HTA arrays.

Authors:  Marijke Van Moerbeke; Adetayo Kasim; Willem Talloen; Joke Reumers; Hinrick W H Göhlmann; Ziv Shkedy
Journal:  BMC Bioinformatics       Date:  2017-05-25       Impact factor: 3.169

5.  Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons.

Authors:  Hai-Qin Huo; Zhuang-Yin Qu; Fang Yuan; Lixiang Ma; Lin Yao; Min Xu; Yao Hu; Jing Ji; Anita Bhattacharyya; Su-Chun Zhang; Yan Liu
Journal:  Stem Cell Reports       Date:  2018-03-08       Impact factor: 7.765

6.  Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Christy M Kelley; Brian E Powers; Ramon Velazquez; Jessica A Ash; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  Brain Pathol       Date:  2013-07-19       Impact factor: 6.508

7.  Tracking the evolution of alternatively spliced exons within the Dscam family.

Authors:  Mack E Crayton; Bradford C Powell; Todd J Vision; Morgan C Giddings
Journal:  BMC Evol Biol       Date:  2006-02-16       Impact factor: 3.260

8.  Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy.

Authors:  Anna Conti; Floriana Fabbrini; Paola D'Agostino; Rosa Negri; Dario Greco; Rita Genesio; Maria D'Armiento; Carlo Olla; Dario Paladini; Mariastella Zannini; Lucio Nitsch
Journal:  BMC Genomics       Date:  2007-08-07       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.